Alder Therapeutics is a brand at the forefront of the next era in cell therapy. With a focus on optimizing pluripotent stem cell differentiation processes, they deliver innovative and high-quality cell therapy products consistently. Their cutting-edge platform ensures reproducibility and robustness in cell manufacturing processes.

Alder Therapeutics prides itself on creating a novel cell therapy platform with best-in-class processes. Their team consists of industry experts, including CEO Kristian Tryggvason, who has over a decade of experience in the cell therapy field. COO Stijn Heessen brings a wealth of knowledge from global regulatory affairs and business development in leading pharmaceutical companies.

CTO Ricardo Baptista, a true pioneer in therapeutic cell manufacturing, combines CMC knowledge with clinical and regulatory strategies. Alder Therapeutics has recently made significant advancements, securing exclusive license agreements for state-of-the-art manufacturing methods for retinal and cardiac cell therapeutic products. With seed funding of 20 MSEK, they aim to develop their initial stem cell therapy programs and expand their team.

To learn more about their revolutionary cell therapy solutions or to discuss a differentiation protocol, simply enter your contact information, and Alder Therapeutics will get in touch. The future of cell therapy starts here